Kevin Church - CHIEF SCIENTIFIC OFFICER at Athira Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
ATHA on Nasdaq
All Insider Reports
All Insider Reports

Kevin Church - trading volume in the past year for Athira Pharma, Inc.

Holdings reported by Kevin Church for Athira Pharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 131K $73.5K $0.56 Jan 2, 2025 Direct
Restricted Stock Units 73.3K $41.2K $0.56 Dec 31, 2024 Direct Common Stock
Stock Option (Right to Buy) 110K Oct 1, 2024 Direct Common Stock

Transactions reported by Kevin Church for Athira Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.